Lantern Pharma Inc. (NASDAQ:LTRN) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to our Fourth Quarter and Year End 2023 Earnings Call. As a reminder, this call is being recorded and all attendees are in a listen-only mode.
Lantern Pharma Inc. (LTRN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Carlson Capital Clint Carlson | 60,000 | $256,800 | -37% | 0.02% |
| 2. | Horizon Asset Management Murray Stahl | 28,791 | $123,225 | -5% | 0% |
| 3. | Citadel Investment Group Ken Griffin | 24,858 | $106,392 | -19% | 0% |
| 4. | 400 | $1,712 | -95% | 0% | |
| 5. | 200 | $856 | -91% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.00 | 10,000 | Director | 10,000 | 2020-06-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.87 | 4,185 | Large Shareholder | 137,832 | 2024-02-29 | Filing | |
| $4.85 | 15,780 | Large Shareholder | 142,017 | 2024-02-28 | Filing | |
| $4.40 | 10,620 | Large Shareholder | 157,797 | 2024-02-27 | Filing | |
| $4.87 | 13,686 | Large Shareholder | 450,118 | 2024-02-29 | Filing | |
| $4.85 | 51,608 | Large Shareholder | 463,804 | 2024-02-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 365,334 | $1,563,629 | 0% | |
| 2. | 165,972 | $710,363 | 0% | |
| 3. | 95,036 | $406,831 | 0% | |
| 4. | 80,000 | $342,400 | 0.27% | |
| 5. | 40,662 | $174,033 | 0.05% |
News See All
11 Best Artificial Intelligence Stocks Under $20 According To Hedge Funds
In this article, we discuss 11 best artificial intelligence stocks under $20.
Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to our Third Quarter 2023 Earnings Call. As a reminder, this call is being recorded and all attendees are in a listen-only mode.
Lantern Pharma Inc. (NASDAQ:LTRN) Q2 2023 Earnings Call Transcript
Nicole Leber: Good afternoon, everyone. I’m Nicole Leber with Investor Relations here at Lantern Pharma. Welcome to our Second Quarter 2023 Earnings Call. I will be your host for today’s call.
Lantern Pharma Inc. (NASDAQ:LTRN) Q1 2023 Earnings Call Transcript
Nicole Leber: Good afternoon, everyone. I'm Nicole Weber with Investor Relations here at Lantern Pharma. Welcome to our First Quarter 2023 Earnings Call. I will be your host for today's call.
Lantern Pharma Inc. (NASDAQ:LTRN) Q4 2022 Earnings Call Transcript
Nicole Leber: Welcome to our fourth quarter and full-year 2022 earnings call. I will be your host for today's call.
Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2022 Earnings Call Transcript
Panna Sharma: Thank you, Nicole. Good afternoon, everyone. And welcome to our third quarter 2022 earnings call.
10 Best Artificial Intelligence Stocks Under $10
According to research conducted by PricewaterhouseCoopers (PwC), 45% of the economic gains by the end of this decade will be driven by the enhancement in AI technology that will provide impetus to consumer...
Is Lantern Pharma Inc. (LTRN) A Good Stock To Buy Now?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
10 Best AI Stocks under $50
In this article, we will take a look at the 10 best AI stocks under $50.
Billionaire Hedge Funds
